| Literature DB >> 19693641 |
Denise Tong1, Sharron Eather, Nicholas Manolios.
Abstract
Lymphoedema is a rare complication of psoriatic arthritis (PsA) and inflammatory joint disease, with no response noted to disease-modifying drugs. However, reports are emerging of a beneficial effect on lymphoedema in patients treated with tumor necrosis factor-alpha antagonists for PsA (Etanercept), rheumatoid arthritis (Etanercept) and ankylosing spondylitis (Infliximab). We describe a psoriatic arthritis patient whose lymphoedema greatly improved following commencement of adalimumab.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19693641 DOI: 10.1007/s10067-009-1259-z
Source DB: PubMed Journal: Clin Rheumatol ISSN: 0770-3198 Impact factor: 2.980